ACM
GBIO

Atika Capital Management’s Generation Bio GBIO Stock Holding History

Atika Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-35,500
Closed -$1.53M – 92
2023
Q1 		$1.53M Buy
+35,500
New +$1.72M 0.23% 72

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Atika Capital Management's GBIO Position: Q2 2023 in Review

Atika Capital Management sold out of Generation Bio (GBIO) in Q2 2023, closing a stake of 35,500 shares — an estimated $1.53M sold.

Atika Capital Management first reported a position in GBIO in Q1 2023 and held it in 1 quarter. The position peaked at $1.53M in Q1 2023. 79 funds tracked by Wall St. Rank hold GBIO as of Q2 2023.

  • Atika Capital Management reported no remaining Generation Bio position as of Q2 2023 after selling out during the quarter.
  • Atika Capital Management sold 35,500 Generation Bio shares in Q2 2023, an estimated $1.53M.
  • Atika Capital Management first reported a position in Generation Bio in Q1 2023 and held it in 1 quarter.
  • Atika Capital Management's Generation Bio position peaked at $1.53M in Q1 2023.
  • 79 funds tracked by Wall St. Rank held Generation Bio as of Q2 2023.

Based on Atika Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.